April 16 (Reuters) - Conduit Pharmaceuticals Inc CDT.O:
CONDUIT PHARMACEUTICALS ANNOUNCES LEADERSHIP CHANGES
CONDUIT PHARMACEUTICALS INC - APPOINTS ANDREW REGAN AS CEO
CONDUIT PHARMACEUTICALS INC - DAVID TAPOLCZAY STEPS DOWN AS CEO AND BOARD MEMBER
Source text: ID:nGNX3PFJ2l
Further company coverage: CDT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.